Fresh analysis reveals that individuals who discontinue blockbuster slimming jabs like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who halt traditional lifestyle regimens.
Published data in a major health publication demonstrates that while overweight people often shed substantial amounts of their body weight while undergoing treatment, the mass returns at an average rate of 0.8 kg per month after stopping.
"Individuals using these treatments must be informed of the risk of rapid rebound weight gain when the treatment concludes," warns researcher Dr. Susan Jebb.
That rate of recovery suggests a reversion to starting mass in about 18 months.
Analyzing Approaches
The study, which reviewed dozens of studies involving thousands of patients, contrasted the outcomes of the injectable medications with other pills.
The team point out that individuals who lose weight through dieting usually experience a more gradual creep back—perhaps 100 grams monthly—once they finish.
Explaining the Rapid Rebound
Doctors suggest the way of the jabs is key to understanding the heightened weight return.
GLP-1 drugs imitate a body's own chemical called GLP-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 concentrations several times higher than normal may cause the body to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' results in hunger is unsuppressed, making overeating much more probable."
An Ongoing Disease?
Health authorities recommend the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians argue that, considering the high risk of weight regain, the therapy might need to be ongoing.
This perspective is echoed by pharmaceutical companies, who note that the findings "underscore the chronic character of obesity," similar to managing conditions like diabetes.
User Accounts
People who have come off the jabs report a intense resurgence of cravings.
"It was like a trigger that goes on and I was suddenly ravenous," said one woman.
The struggle is worsened if patients have not developed lasting dietary or behavioural changes during therapy.
Widespread Adoption
Survey data indicate that a significant number of people in the UK have used these injections in the past year, with interest remaining high.
- Adoption is greater among women compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
In conclusion, experts stress that while GLP-1 drugs are potent agents for weight loss, they are not a magic fix and maintained weight loss likely depends on ongoing lifestyle changes.
